U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. RAPLIXA
  1. Approved Blood Products

STN: 125523
Proper Name: Fibrin Sealant (Human)
Tradename: RAPLIXA
Manufacturer: The Medicines Company
Indication:

  • Indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.

Product Information

Supporting Documents

Back to Top